Anti-TRAM2 monoclonal antibody

Pre-made anti-TRAM2 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to TRAM2/TRAM2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2172-Ab-1/ GM-Tg-hg-IP2172-Ab-2Anti-Human TRAM2 monoclonal antibodyHuman
GM-Tg-rg-IP2172-Ab-1/ GM-Tg-rg-IP2172-Ab-2Anti-Rat TRAM2 monoclonal antibodyRat
GM-Tg-mg-IP2172-Ab-1/ GM-Tg-mg-IP2172-Ab-2Anti-Mouse TRAM2 monoclonal antibodyMouse
GM-Tg-cynog-IP2172-Ab-1/ GM-Tg-cynog-IP2172-Ab-2Anti-Cynomolgus/ Rhesus macaque TRAM2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2172-Ab-1/ GM-Tg-felg-IP2172-Ab-2Anti-Feline TRAM2 monoclonal antibodyFeline
GM-Tg-cang-IP2172-Ab-1/ GM-Tg-cang-IP2172-Ab-2Anti-Canine TRAM2 monoclonal antibodyCanine
GM-Tg-bovg-IP2172-Ab-1/ GM-Tg-bovg-IP2172-Ab-2Anti-Bovine TRAM2 monoclonal antibodyBovine
GM-Tg-equg-IP2172-Ab-1/ GM-Tg-equg-IP2172-Ab-2Anti-Equine TRAM2 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2172-Ab-1/ GM-Tg-hg-IP2172-Ab-2; GM-Tg-rg-IP2172-Ab-1/ GM-Tg-rg-IP2172-Ab-2;
GM-Tg-mg-IP2172-Ab-1/ GM-Tg-mg-IP2172-Ab-2; GM-Tg-cynog-IP2172-Ab-1/ GM-Tg-cynog-IP2172-Ab-2;
GM-Tg-felg-IP2172-Ab-1/ GM-Tg-felg-IP2172-Ab-2; GM-Tg-cang-IP2172-Ab-1/ GM-Tg-cang-IP2172-Ab-2;
GM-Tg-bovg-IP2172-Ab-1/ GM-Tg-bovg-IP2172-Ab-2; GM-Tg-equg-IP2172-Ab-1/ GM-Tg-equg-IP2172-Ab-2
Products NameAnti-TRAM2 monoclonal antibody
Formatmab
Target NameTRAM2
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-TRAM2 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2172-Ag-1Recombinant multi-species TRAM2 protein
    ORF Viral VectorpGMLP002475human TRAM2 Lentivirus plasmid
    ORF Viral VectorvGMLP002475human TRAM2 Lentivirus particle
    ORF Viral VectorpGMLPm002062mouse Tram2 Lentivirus plasmid
    ORF Viral VectorvGMLPm002062mouse Tram2 Lentivirus particle


    Target information

    Target IDGM-IP2172
    Target NameTRAM2
    Gene ID9697,170829,100361830,708636,474936,101084287,617287,100069225
    Gene Symbol and SynonymsC330003D03Rik,TRAM2
    Uniprot AccessionQ15035
    Uniprot Entry NameTRAM2_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000065308
    Target ClassificationN/A

    The target: TRAM2, gene name: TRAM2, also named as . TRAM2 is a component of the translocon, a gated macromolecular channel that controls the posttranslational processing of nascent secretory and membrane proteins at the endoplasmic reticulum (ER) membrane.[supplied by OMIM, Jul 2004].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.